Long-term rhythm control of drug-refractory atrial fibrillation with "hybrid therapy" incorporating dual-site right atrial pacing, antiarrhythmic drugs, and right atrial ablation

American Journal of Cardiology

Volumn 93, Issue 5, 2004, Pages 569-575

  Madan, Nandini ^a   Saksena, Sanjeev ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT;

ADULT; AGED; ARTICLE; CARDIOVERSION; CATHETER ABLATION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART CATHETERIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; PRIORITY JOURNAL; RECURRENT DISEASE; SURVIVAL RATE; SYMPTOMATOLOGY; TREATMENT INDICATION;

AGED; AGED, 80 AND OVER; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ATRIAL FUNCTION; CARDIAC PACING, ARTIFICIAL; CATHETER ABLATION; COMBINED MODALITY THERAPY; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; TIME FACTORS; TREATMENT OUTCOME;

EID: 1442348782     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2003.11.020     Document Type: Article

References (22)

1. Gianfranchi L., Brignole M., Menozzi C., Lolli G., Bottoni N. Progression of permanent atrial fibrillation after atrioventricular junction ablation and dual-chamber pacemaker implantation in patients with paroxysmal atrial fibrillation. Am J Cardiol. 81:1998;351-354.
2. Sakamoto H., Kuryabashi M., Nagai R. Prediction of transition to chronic atrial fibrillation in patients with paroxysmal atrial fibrillation. Circulation. 98:1998;1044-1045.
3. Wyse D.G., Waldo A.L., DiMarco J.P., Domanski M.J., Rosenberg Y., Schron E.B., Kellen J.C., Greene H.L., Mickel M.C., Dalquist J.E., Corley S.D., Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 347:2002;1825-1833.
4. Gillis A.M., Connolly S.J., Lacombe P., Philippon F., Dubuc M., Kerr C.R., Yee R., Rose M.S., Newman D., Kavanagh K.M., et al. Randomized crossover comparison of DDDR versus VDD pacing after atrioventricular junction ablation for the prevention of atrial fibrillation. The Atrial Pacing Peri Ablation for Paroxysmal Atrial Fibrillation (PA3) Study Investigators. Circulation. 12:2000;121-130.
5. Carlsson J., Miketic S., Windeler J., Cuneo A., Haun S., Micus S., Walter S., Tebbe U., STAF Investigators. Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation the Strategies of Treatment of Atrial Fibrillation (STAF) study. J Am Coll Cardiol. 41:2003;1690-1696.
6. Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kampo, Kingma T, Said SA, Darmanata JI, Timmermans AJM, Tijssen JGP, Crijns HJGM, for the RACE Study Group. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002;347;1834-1840
7. Gregoratos G., Cheitlin M.D., Conill A., Epstein A.E., Fellows C., Ferguson T.B. Jr, Freedman R.A., Hlatky M.A., Naccarelli G.V., Saksena S., et al. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices executive summary. Circulation. 97:1998;1325-1335.
8. Fuster V., Ryden L.E., Asinger R.W., Cannom D.S., Crijns H.J., Frye R.L., Halperin J.L., Kaye G.N., Klein W.W., Levy S., et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation executive summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in Collaboration With the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol. 38:2001;1231-1266.
9. Fitts S.M., Hill M.R.S., Mehra R., Freidman P., Hammill S., Kay G.N., Prakash A.M., Webb C., Saksena S., DAPAFF Phase 1 Investigators. Design and Implementation of the Dual Site Pacing to prevent Atrial Fibrillation (DAPAFF) clinical trial. J Intervent Cardiol Electrophysiol. 2:1998;139-144.
10. Saksena S., Prakash A., Hill M., Krol R.B., Munsif A.M., Mathew P.P., Mehra R. Prevention of recurrent atrial fibrillation with chronic dual site atrial pacing. J Am Coll Cardiol. 28:1996;687-694.
11. Saksena S., Prakash A., Ziegler P., Hummel J.D., Freidman P., Plumb V.J., Wyse D.G., Johnson E., Fitts S., Mehra R. The Dual Site Atrial Pacing for Permanent Atrial Fibrillation (DAPPAF) trial improved suppression of drug refractory atrial fibrillation with dual site atrial pacing and antiarrhythmic drug therapy. J Am Coll Cardiol. 38:2001;598-599.
12. Garg A., Finneran W., Mollerus M., Garg A., Finneran W., Mollerus M., Birgersdotter-Green U., Fujimura O., Tone L., Feld G.K. Right atrial compartmentalization using radiofrequency catheter ablation for management of patients with refractory atrial fibrillation. J Cardiovasc Electrophysiol. 10:1999;763-771.
13. Cox J.L., Ad N., Palazzo T., Fitzpatrick S., Suyderhoud J.P., DeGroot K.W., Pirovic E.A., Lou H.C., Duvall W.Z., Kim Y.D. Current status of the Maze procedure for the treatment of atrial fibrillation. Semin Thorac Cardiovasc Surg. 12:2000;15-19.
14. Haissaguerre M., Jais P., Shah D.C., Takahashi A., Hocini M., Quiniou G., Garrigue S., Le Mouroux A. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 339:1998;659-666.
15. Chen S.A., Hsieh M., Tai C., Tsai C.F., Prakash V.S., Yu W.C., Hsu T.L., Ding Y.A., Chang M.S. Initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. Electrophysiological characteristics, pharmacological responses and effects of radiofrequency ablation. Circulation. 100:1999;1879-1886.
16. Garrigue S., Barold S.S., Cazeau S., Gencel L., Jais P., Hassaguerre M., Clement J. Prevention of atrial arrhythmias during DDD pacing by atrial overdrive. Pacing Clin Electrophysiol. 21:1998;1751-1759.
17. Abe Y., Fukunami M., Yamala T., Ohmoi M., Shimongata T., Kumagai K., Kim J., Sanada S., Hori M., Hoki N. Prediction of transition to chronic atrial fibrillation in patients with paroxysmal atrial fibrillation by signal averaged electrocardiography a prospective study. Circulation. 96:1997;2612-2616.
18. Prakash A., Delfaut P., Krol R.B., Saksena S., Krol R.B., Phillip G. Regional right atrial and left atrial activation patterns during single and dual site pacing in patients with atrial fibrillation. Am J Cardiol. 82:1998;1197-1204.
19. Prakash A., Saksena S., Krol R.B., Filipecki A., Phillip G. Catheter ablation of inducible atrial flutter in combination with atrial pacing and antiarrhythmic drugs (hybrid therapy) improves rhythm control in patients with refractory atrial fibrillation. J Intervent Cardiol Electrophysiol. 6:2002;165-174.
20. Delfaut P., Saksena S., Prakash A., Krol R.B. Long-term outcome of patients with drug-refractory atrial flutter and fibrillation after single- and dual-site right atrial pacing for arrhythmia prevention. J Am Coll Cardiol. 32:1998;1900-1908.
21. Filipecki A., Saksena S., Prakash A., Philip G. Three dimensional non-contact mapping demonstrates synergistic electrophysiologic effects of multisite atrial pacing and linear atrial ablation in patients with refractory atrial fibrillation. Am J Cardiol. 41:(suppl A):2003;1017-1023.
22. Benjamin E., Wolf P.A., D'Agostino R.B., Silbershatz H., Kannel W., Levy D. Impact of atrial fibrillation on the risk of death the Framingham Heart Study. Circulation. 8:1998;946-952.